CanPharma
CanPharma GmbH is a GMP and GDP certified German pharmaceutical company that wholesale-distributes premium cannabis genetics and provides EU/UK market access services to breeders.
- Company typePrivate
- Founded-
- HeadquartersOranienburg, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What CanPharma does
CanPharma GmbH is a privately held German pharmaceutical company headquartered in Oranienburg that operates in the European medical cannabis industry. The company holds GMP (Good Manufacturing Practice) and GDP (Good Distribution Practice) certifications, along with German licences for the manufacturing, import, and trade of pharmaceuticals and the trade in controlled substances, positioning it among a narrow set of fully licensed cannabis operators in Europe. Its core activity is the wholesale distribution of premium cannabis genetics to wholesale and retail partners in the EU and the UK.
CanPharma firmographics
Firmographics- Name
- CanPharma
- Legal name
- CanPharma GmbH
- Website
- https://canpharma.eu
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CanPharma GmbH is a GMP and GDP certified German pharmaceutical company that wholesale-distributes premium cannabis genetics and provides EU/UK market access services to breeders.
- Ownership category
- akta.pro rank
Where CanPharma is headquartered
LocationHeadquarters
- HQ city
- Oranienburg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
CanPharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Others
Distribution channels1 record
Marketing channels3 records
CanPharma product offering
Product offeringCore offering
CanPharma is a GMP- and GDP-certified pharmaceutical company that supplies premium cannabis genetics to wholesale and retail partners across the EU and UK. It complements this core product line with market-access services that help breeders and geneticists enter and operate in the European cannabis market under its pharmaceutical and controlled-substance licenses.
Product overview
CanPharma operates as a unified pharmaceutical product and service offering focused on the European cannabis industry. The company provides two interconnected offerings: premium cannabis genetics as its core product line supplied to wholesale and retail partners across the EU and UK, complemented by market access services that enable breeders to enter these same markets. As a GMP and GDP certified pharmaceutical company, the product-service combination creates an end-to-end solution from genetic development through market distribution.
Differentiator
Problem solved
Functional benefit
Products and services
- Premium Cannabis Genetics
Companies that use CanPharma
Customer profileSegments2 records
Ideal customer profiles2 records
CanPharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CanPharma partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
CanPharma competitors and assessment
Company assessmentDirect peers
- Cansativa: German cannabis wholesale and B2B distribution platform connecting producers with pharmacies; comparable to CanPharma's EU wholesale distribution focus and regulatory positioning.
- Sanity Group: Berlin-based European medical cannabis company with pharmaceutical licensing for cultivation and distribution; broader portfolio but directly comparable to CanPharma in GMP-certified cannabis operations.
- Demecan: German vertically integrated medical cannabis producer and distributor with pharmaceutical licenses; competes head-to-head with CanPharma for the same EU wholesale and pharmacy customers.
- Cannamedical Pharma: Germany-based pharmaceutical-grade medical cannabis wholesaler with GMP/GDP licenses, supplying EU pharmacies and wholesalers — directly mirrors CanPharma's pharma-certified cannabis distribution model.
- Nimbus Health: Germany-based medical cannabis importer and distributor operating under pharmaceutical licenses; directly comparable to CanPharma's controlled-substance import/trade business.
Regional players
- GH Medical Pharma: Germany-based cannabis pharmaceutical distributor with import/wholesale licenses; comparable pharma-grade cannabis wholesale model with primary focus on the German and EU market.
Broad incumbents
- Tilray Brands (European operations): Global cannabis company with significant EU medical cannabis distribution; larger scale incumbent competing for the same EU/UK wholesale and pharmacy demand that CanPharma serves.
- STADA Arzneimittel (cannabis portfolio): Major German generic pharmaceutical company that has entered medical cannabis distribution; broader pharma portfolio but a relevant incumbent serving the same EU wholesale and pharmacy channels.
- Canopy Growth (European operations): Global cannabis producer with EU medical cannabis supply infrastructure; broad incumbent whose European wholesale and import activities overlap with CanPharma's positioning.
- Aurora Cannabis (European operations): Canadian-listed global cannabis producer with established EU medical cannabis distribution; a larger incumbent whose EU wholesale activities overlap with CanPharma's buyer and supplier networks.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
CanPharma social profiles
Digital presenceCanPharma compliance and trust
Trust signalCompliance2 records
CanPharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
CanPharma leadership team
Management profileNumber of profiles
Profiles1 record
CanPharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CanPharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CanPharma
What does CanPharma do?
CanPharma is a GMP- and GDP-certified pharmaceutical company that supplies premium cannabis genetics to wholesale and retail partners across the EU and UK. It complements this core product line with market-access services that help breeders and geneticists enter and operate in the European cannabis market under its pharmaceutical and controlled-substance licenses.
Is CanPharma a public or private company?
CanPharma is a private company. It is classified as unknown and is currently operating.
When was CanPharma founded?
CanPharma was founded in -1. It employs 11 to 50 people.
Where is CanPharma based?
CanPharma is headquartered in Oranienburg, Germany, in the Europe region.
Who are CanPharma's main competitors?
Direct peers on record are Cansativa, Sanity Group, Demecan, Cannamedical Pharma and Nimbus Health. GH Medical Pharma is listed as a regional player. Broad incumbents are Tilray Brands (European operations), STADA Arzneimittel (cannabis portfolio), Canopy Growth (European operations) and Aurora Cannabis (European operations).
Does CanPharma have an API?
No public API is recorded for CanPharma.